- Home>
- Specialties>
- Infectious Diseases>
- Hepatitis
Search for Hepatitis in Infectious Diseases
Physician-authored summaries on the latest research on hepatitis, editorials on hepatitis, and perspectives on hepatitis - drawn from the top medical journals.
Sort by:
Items 1 to 20 of 218 results - Relevance
- Date
You searched for: hepatitis in Infectious Diseases
-
A Novel Adenovirus with Cross-Species Transmission
- July 27, 2011
- Thomas Glück, MD
- Infectious Diseases
A newly identified adenovirus responsible for a deadly outbreak among monkeys was transmitted to a researcher — and to the researcher's family.- Reviewing:
- Chen EC et al., PLoS Pathog 2011 Jul 14; 7:e1002155.
-
Exploring Immunity to Hepatitis C
Researchers have identified an anti–hepatitis C monoclonal antibody that is broadly cross-reactive and is protective in a mouse model.- Reviewing:
- Giang E et al., Proc Natl Acad Sci U S A 2012 Apr 17; 109:6205.
-
Transmission of Hepatitis B Virus from Blood Donors with Occult Infection? Free
- March 23, 2011
- Neil M. Ampel, MD
- Infectious Diseases
Occult HBV infection was uncommon among blood donors in Hong Kong, and HBV transmission from donors with such infection was relatively rare.- Reviewing:
- Yuen M-F et al., Clin Infect Dis 2011 Mar 1; 52:624.
-
Hepatitis B in the U.S., 1999–2008
- March 2, 2011
- Stephen G. Baum, MD
- Infectious Diseases
The rates of HBV exposure and chronic infection were significantly lower in 1999–2008 than in 1988–1994; 2-year-olds had higher immunity rates than adults.- Reviewing:
- Ioannou GN., Ann Intern Med 2011 Mar 1; 154:319.
-
Hepatitis A in the U.S.
- November 10, 2010
- Larry M. Baddour, MD
- Infectious Diseases
International travel was the predominant risk factor for infection.- Reviewing:
- Klevens RM et al., Arch Intern Med 2010 Nov 8; 170:1811. Andersson KL et al., Arch Intern Med 2010 Nov 8; 170:1818.
-
Predicting Treatment Success for Hepatitis C Among HIV-Infected Patients
- October 20, 2010
- Neil M. Ampel, MD
- Infectious Diseases
The rs12979860 CC genotype was associated with an increased likelihood of sustained viral response after pegylated interferon alfa-2/ribavirin treatment.- Reviewing:
- Pineda JA et al., Clin Infect Dis 2010 Oct 1; 51:788.
-
Hepatitis E Epidemiology in Bangladesh
- September 22, 2010
- Mary E. Wilson, MD
- Infectious Diseases
In a rural area, the incidence of hepatitis E infection was 64 per 1000 person-years.- Reviewing:
- Labrique AB et al., Am J Epidemiol 2010 Aug 26;:
-
Pegylated Interferon Alfa for Acute Hepatitis C
- September 15, 2010
- Neil M. Ampel, MD
- Infectious Diseases
Pegylated interferon alfa-2a at 135 µg weekly for 24 weeks cleared hepatitis C viremia in 89% of hemodialysis patients with acute infection.- Reviewing:
- Liu C-H et al., Clin Infect Dis 2010 Sep 1; 51:541.
-
Hepatitis C Virus Survival in Syringes
- September 8, 2010
- Rajesh T. Gandhi, MD
- Infectious Diseases
Under certain conditions, HCV can survive longer than 2 months.- Reviewing:
- Paintsil E et al., J Infect Dis 2010 Oct 1; 202:984. Rich JD and Taylor LE., J Infect Dis 2010 Oct 1; 202:981.
-
Hepatitis E Vaccine Efficacious and Safe Free
- September 1, 2010
- Mary E. Wilson, MD
- Infectious Diseases
In a large phase III trial conducted among adults in China, three doses of the vaccine had 100% efficacy at 1 year.- Reviewing:
- Zhu F-C et al., Lancet 2010 Aug 23;: Holmberg SD., Lancet 2010 Aug 23;:
-
Hepatitis C Virus Transmission at an Endoscopy Clinic Free
- July 21, 2010
- Neil M. Ampel, MD
- Infectious Diseases
Eight cases were identified; contamination and reuse of open propofol vials was the likely source.- Reviewing:
- Fischer GE et al., Clin Infect Dis 2010 Aug 1; 51:267.
-
Vaccination's Effect on Hepatitis B Free
- June 23, 2010
- Larry M. Baddour, MD
- Infectious Diseases
A vaccination program initiated in the U.S. nearly 2 decades ago has reduced the prevalence of this infection in people aged 6 to 49.- Reviewing:
- Wasley A et al., J Infect Dis 2010 Jul 15; 202:192.
-
Hepatitis E Outbreak Among Cruise Ship Passengers
- November 4, 2009
- Mary E. Wilson, MD
- Infectious Diseases
Overall, 4% of passengers returning from a 3-month world cruise tested positive for recent HEV infection; one third of these individuals had symptomatic hepatitis.- Reviewing:
- Said B et al., Emerg Infect Dis 2009 Nov; 15:1738.
-
Hepatitis B Guidelines, Updated
- September 30, 2009
- Rajesh T. Gandhi, MD
- Infectious Diseases
This revised document provides useful information about the prevention, diagnosis, and management of HBV infection.- Reviewing:
- Lok ASF and McMahon BJ., Hepatology 2009 Sep; 50:661. ,;:
-
Interferon for Older Patients with Hepatitis C?
- May 27, 2009
- Neil M. Ampel, MD
- Infectious Diseases
IFN therapy was associated with improved survival and reduced risk for hepatocellular carcinoma in those with initial platelet counts <150,000 mm3.- Reviewing:
- Ikeda K et al., Am J Med 2009 May; 122:479.
-
Nitazoxanide for Chronic Hepatitis C
- April 1, 2009
- Larry M. Baddour, MD
- Infectious Diseases
In patients with genotype 4 infection, virologic response rates improved when nitazoxanide was added to standard therapy.- Reviewing:
- Rossignol J-F et al., Gastroenterology 2009 Mar; 136:856. Darling JM and Fried MW., Gastroenterology 2009 Mar; 136:760.
-
Potential Sources of Hepatitis E Virus
- March 4, 2009
- Mary E. Wilson, MD
- Infectious Diseases
HEV RNA sequences were detected in swine feces and river water in the Netherlands.- Reviewing:
- Rutjes SA et al., Emerg Infect Dis 2009 Mar; 15:381.
-
Hepatitis Outbreaks in Nonhospital Healthcare Facilities Free
- January 14, 2009
- Stephen G. Baum, MD
- Infectious Diseases
Lapses in infection-control practices at outpatient care settings resulted in hundreds of hepatitis B and C cases and put thousands of people at risk.- Reviewing:
- Thompson ND et al., Ann Intern Med 2009 Jan 6; 150:33.
-
Maintenance Peginterferon Therapy Not Helpful in Advanced Chronic Hepatitis C Free
- December 10, 2008
- Larry M. Baddour, MD
- Infectious Diseases
Patients without initial responses to peginterferon and ribavirin did not benefit from long-term low-dose peginterferon therapy in the HALT-C trial.- Reviewing:
- Di Bisceglie AM et al., N Engl J Med 2008 Dec 4; 359:2429.
-
Treating Chronic Hepatitis B — Tenofovir DF vs. Adefovir Dipivoxil
- December 10, 2008
- Larry M. Baddour, MD
- Infectious Diseases
In studies of both HBeAg-negative and HBeAg-positive patients, tenofovir disoproxil fumarate was superior to adefovir dipivoxil.- Reviewing:
- Marcellin P et al., N Engl J Med 2008 Dec 4; 359:2442.
Sort by:
Items 1 to 20 of 218 results - Relevance
- Date
